{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:57:26Z","timestamp":1793631446112,"version":"4.5.1"},"reference-count":22,"publisher":"Society of Nuclear Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,7,13]]},"published-print":{"date-parts":[[2026,11]]},"DOI":"10.2967\/jnumed.125.271853","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:55:20Z","timestamp":1786031720000},"page":"1719-1724","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Radiochemistry: An Integrated Translational Blueprint for the Next Generation of Radionuclide Ligand Conjugates"],"prefix":"10.2967","volume":"67","author":[{"given":"Chen","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2026110206250892000_67.11.1719.1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.acr.2024.07.004","article-title":"Advances in prostate cancer treatment: radionuclide therapy for prostate cancer","volume":"164","author":"Zhong","year":"2024","journal-title":"Adv Cancer Res."},{"key":"2026110206250892000_67.11.1719.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.04.010"},{"key":"2026110206250892000_67.11.1719.3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on Prostate Cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol."},{"key":"2026110206250892000_67.11.1719.4","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3390\/cancers17122039","article-title":"Peptide receptor radionuclide therapy in patients with advanced, recurrent or progressive meningioma: an updated systematic review and meta-analysis","volume":"17","author":"Muoio","year":"2025","journal-title":"Cancers (Basel)."},{"key":"2026110206250892000_67.11.1719.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268136"},{"key":"2026110206250892000_67.11.1719.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269776"},{"key":"2026110206250892000_67.11.1719.7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00259-024-06963-9","article-title":"EANM expert opinion: how can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose\u2013response and threshold absorbed doses","volume":"52","author":"Pouget","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026110206250892000_67.11.1719.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267547"},{"key":"2026110206250892000_67.11.1719.9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jimaging10010027","article-title":"The challenge of single-photon emission computed tomography image segmentation in the internal dosimetry of 177Lu molecular therapies","volume":"10","author":"Gawel","year":"2024","journal-title":"J Imaging."},{"key":"2026110206250892000_67.11.1719.10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.23736\/S1824-4785.24.03571-4","article-title":"177Lu-labeled somatostatin receptor targeted radionuclide therapy dosimetry in meningioma: a systematic review","volume":"68","author":"Boursier","year":"2024","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2026110206250892000_67.11.1719.11","doi-asserted-by":"crossref","first-page":"e70103","DOI":"10.1111\/jne.70103","article-title":"Systematic review and meta-analysis of the efficacy and safety of [177Lu]Lu-edotreotide ([177Lu]Lu-DOTATOC) for the treatment of neuroendocrine tumors","volume":"38","author":"Baum","year":"2026","journal-title":"J Neuroendocrinol."},{"key":"2026110206250892000_67.11.1719.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267452"},{"key":"2026110206250892000_67.11.1719.13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3390\/ph17081031","article-title":"Future treatment strategies for cancer patients combining targeted alpha therapy with pillars of cancer treatment: external beam radiation therapy, checkpoint inhibition immunotherapy, cytostatic chemotherapy, and brachytherapy","volume":"17","author":"Winter","year":"2024","journal-title":"Pharmaceuticals (Basel)."},{"key":"2026110206250892000_67.11.1719.14","first-page":"967","article-title":"Unveiling the tumor microenvironment through fibroblast activation protein targeting in diagnostic nuclear medicine: a didactic review on biological rationales and key imaging agents","volume":"13","author":"Fouillet","year":"2024","journal-title":"Biology (Basel)."},{"key":"2026110206250892000_67.11.1719.15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12880-025-01571-x","article-title":"Investigating the significance of SPECT\/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review","volume":"25","author":"Alkahtani","year":"2025","journal-title":"BMC Med Imaging."},{"key":"2026110206250892000_67.11.1719.16","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.7150\/thno.100555","article-title":"Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease management","volume":"14","author":"Hansen","year":"2024","journal-title":"Theranostics."},{"key":"2026110206250892000_67.11.1719.17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.euo.2025.10.011","article-title":"PARP inhibitors in metastatic castration-resistant prostate cancer: rationale, mechanisms, and clinical applications","volume":"9","author":"Oudard","year":"2026","journal-title":"Eur Urol Oncol."},{"key":"2026110206250892000_67.11.1719.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07461-6"},{"key":"2026110206250892000_67.11.1719.19","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/RLU.0000000000005980","article-title":"Targeted radionuclide therapy in diffuse intrinsic brainstem gliomas: exploring options beyond the finish line","volume":"51","author":"Dharmashaktu","year":"2026","journal-title":"Clin Nucl Med."},{"key":"2026110206250892000_67.11.1719.20","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1093\/neuonc\/noae125","article-title":"Targeted radionuclide therapy for gliomas: emerging clinical trial landscape","volume":"26(suppl 9)","author":"Weller","year":"2024","journal-title":"Neuro Oncol."},{"key":"2026110206250892000_67.11.1719.21","doi-asserted-by":"crossref","first-page":"1445191","DOI":"10.3389\/fonc.2024.1445191","article-title":"Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review","volume":"14","author":"Sanwick","year":"2024","journal-title":"Front Oncol."},{"key":"2026110206250892000_67.11.1719.22","doi-asserted-by":"crossref","first-page":"108970","DOI":"10.1016\/j.nucmedbio.2024.108970","article-title":"Convection-enhanced delivery of [177Lu]Lu-labeled gold nanoparticles combined with anti-PD1 checkpoint immunotherapy improves the survival of immunocompetent C57BL\/6J mice with orthotopic GL261 murine glioma tumors","volume":"140-141","author":"Georgiou","year":"2025","journal-title":"Nucl Med Biol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271853","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:25:29Z","timestamp":1793629529000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11,2]]},"published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.2967\/jnumed.125.271853"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271853","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}